Condition
In Stent Restenosis
Total Trials
6
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed4
Unknown1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07206082Active Not Recruiting
Coronary Laser in Undilatable or Uncrossable Lesions
NCT04240444Not ApplicableCompleted
Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis
NCT05112250CompletedPrimary
IVL for Stent Underexpantsion
NCT04415216CompletedPrimary
DEB vs Thin-DES in DES-ISR: Long Term Outcomes (DEB Dragon Registry)
NCT04518826UnknownPrimary
A Comparison Between FFR Guided and CAG Guided Treatment Using DEB in ISR of DES
NCT00485004Phase 4CompletedPrimary
Focal In-stent Restenosis After Drug-Eluting Stent
Showing all 6 trials